Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Do ovarian androgens support early follicle development and granulosa cell sensitivity to FSH?

Low ovarian androgen availability can contribute to a poorer ovarian response and signaling of diminished ovarian reserve.

SupportedJune 19, 202614 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Ovarian androgens (including testosterone and DHEA-derived androgens) support early follicle development and granulosa cell sensitivity to FSH, so low androgen availability can contribute to a poorer ovarian response and diminished ovarian reserve signaling.

laying out figure…
All 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that ovarian androgens (testosterone and DHEA-derived androgens) prime early follicles and increase granulosa cell sensitivity to FSH, promoting recruitment and growth. Mechanistically, androgens act via AR-mediated pathways (including PI3K/Akt and IGF‑1) and upregulate FSH receptor expression to lower the FSH threshold for follicle maturation; consequently, low androgen levels correlate with lower reserve markers and reduced clinical response.

Verified conclusion

In the context of reproductive aging and ovarian physiology, particularly for individuals in their late 30s, the role of androgens has emerged as a critical factor in understanding follicular health and response to stimulation.

Clinical and effectiveness evidence

Androgen levels, including testosterone and dehydroepiandrosterone (DHEA), are closely linked to markers of ovarian reserve and clinical response.

  • Response Correlation: Studies categorized by the POSEIDON criteria (specifically group 3, younger women with low reserve) show that significant hypoandrogenemia across serum testosterone, androstenedione, and DHEA-S is a distinguishing feature. Low androgen levels correlate directly with lower anti-Müllerian hormone (AMH) and decreased antral follicle counts (AFC).
  • Supplementation Outcomes: Research into androgen priming suggests clinical benefits for poor responders. Meta-analyses have indicated that DHEA and testosterone supplementation can improve oocyte yield and, in some populations, clinical pregnancy rates, although results can vary based on the specific patient subgroup and diagnostic criteria used (e.g., the Bologna criteria).

Mechanistic explanations

Androgens act as fundamental "priming" agents that prepare follicles for the later stages of development.

  • Follicular Recruitment: Androgens interact with the androgen receptor (AR) on granulosa cells of preantral follicles to promote the transition from the primordial to the primary stage. This process involves the PI3K/Akt pathway and the upregulation of insulin-like growth factor-1 (IGF-1), which facilitates the recruitment of follicles into the growing pool.
  • FSH Sensitization: A critical function of androgens is increasing granulosa cell sensitivity to follicle-stimulating hormone (FSH). Androgens upregulate FSH receptor (FSHR) expression via the miRNA-126* axis and by stimulating the LRH-1 promoter. This increase in receptors leads to higher FSH-induced cAMP production, effectively lowering the threshold of FSH required for a follicle to continue its maturation.

Practical considerations

While androgens are essential for healthy follicular initiation, their effects are characterized by a biphasic response. Physiological levels support growth, but excessive levels—often seen in conditions like PCOS—can lead to follicular arrest and atresia. For patients experiencing diminished ovarian reserve, the deficit in these precursors can lead to a "blunted" response to gonadotropins during fertility treatments.

Bottom line

Ovarian androgens are essential for early follicle development and for sensitizing granulosa cells to FSH. Low androgen availability is a clinically recognized contributor to poor ovarian response and diminished ovarian reserve signaling, effectively limiting the pool of follicles available for recruitment and maturation.

References

  1. The Role of Androgen Hormones in Early Follicular Development — pmc.ncbi.nlm.nih.gov ↗
  2. Androgen Stimulates Growth of Mouse Preantral Follicles In Vitro: Interaction With Follicle-Stimulating Hormone and With Growth Factors of the TGFβ Superfamily — pmc.ncbi.nlm.nih.gov ↗
  3. The Role of Androgens in Mammals Folliculogenesis — seer.ufrgs.br ↗
  4. Androgen receptor and miRNA-126* axis controls follicle-stimulating hormone receptor expression in porcine ovarian granulosa cells. — academic.oup.com ↗
  5. Transcripts Encoding the Androgen Receptor and IGF-Related Molecules Are Differently Expressed in Human Granulosa Cells From Primordial and Primary Follicles — frontiersin.org ↗
  6. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? — pmc.ncbi.nlm.nih.gov ↗
  7. Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials. — linkinghub.elsevier.com ↗
  8. The auxiliary effect of oral nutritional supplements on fertility in women with diminished ovarian reserve: a systematic review and meta-analysis — tandfonline.com ↗
  9. Androgens improve ovarian follicle function impaired by glucocorticoids through an androgen-IGF1-FSH synergistic effect — pmc.ncbi.nlm.nih.gov ↗
  10. Androgens Profile in Blood Serum and Follicular Fluid of Women With Poor Ovarian Response During Controlled Ovarian Stimulation Reveals Differences Amongst POSEIDON Stratification Groups: A Pilot Study — frontiersin.org ↗
  11. Androgens Profile in Blood Serum and Follicular Fluid of Women With Poor Ovarian Response During Controlled Ovarian Stimulation Reveals Differences Amongst POSEIDON Stratification Groups: A Pilot Study — pmc.ncbi.nlm.nih.gov ↗
  12. The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency — pmc.ncbi.nlm.nih.gov ↗
  13. Androgens Regulate Ovarian Gene Expression Through Modulation of Ezh2 Expression and Activity — pmc.ncbi.nlm.nih.gov ↗
  14. Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR) — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→